Pretransplant Induction Regimens for Multiple Myeloma

被引：1
|
作者：
Vesole, David H. [1 ]
Siegel, David S. [1 ]
机构：
[1] Hackensack UMC, Hackensack, NJ 07601 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 02期
关键词：
STEM-CELL TRANSPLANTATION; DISEASE; SINGLE;
D O I：
10.1016/j.bbmt.2014.12.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：200 / 201
页数：2
相关论文
共 50 条
  • [31] Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response
    Pasvolsky, Oren
    Abid, Muhammad Bilal
    Milton, Denai R.
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Jatoi, Asiya
    Khan, Hina N.
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Tang, Guilin
    Siddiqui, Umer
    Aljawai, Yosra
    Kebriaei, Partow
    Lee, Hans C.
    Patel, Krina K.
    Gaballa, Mahmoud R.
    Thomas, Sheeba K.
    Orlowski, Robert Z.
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Qazilbash, Muzaffar H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2025,
  • [32] Optimizing induction and pretransplant consolidation for myeloma: Results of Myeloma XI, a phase III trial comparing different IMiDs.
    Pawlyn, Charlotte
    Davies, Faith E.
    Cairns, David A.
    Gregory, Waiter
    Quartilho, Ana
    Ouzman, Jacqueline
    Howard, Helen C.
    Collett, Corinne
    Lindsay, Jindriska
    Cook, Gordon
    Milligan, Donald
    Chapman, Claire
    Allotey, David
    Owen, Roger G.
    Drayson, Mark G.
    Russell, Nigel
    Jackson, Graham H.
    Morgan, Gareth J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Transforming Outcomes in Multiple Myeloma With Antibody-Based Regimens
    Jackson, Graham
    ONCOLOGY-NEW YORK, 2021, 35 (09): : 598 - 603
  • [34] Outcome of patients with multiple myeloma and renal failure on novel regimens
    Soleymanian, Tayebeh
    Soleimani, Adel
    Musavi, Asadollah
    Mojtahedi, Kourosh
    Hamid, Gholamreza
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2016, 27 (02) : 335 - 340
  • [35] Mobilization and engraftment of autologous stem cells under different induction regimens in Multiple Myeloma patients: A single center experience
    Leypoldt, L.
    Schieferdecker, A.
    Geffken, M.
    Peine, S.
    Bokemeyer, C.
    Weisel, K.
    Asemissen, A. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 106 - 106
  • [36] New regimens and directions in the management of newly diagnosed multiple myeloma
    Bal, Susan
    Giri, Smith
    Godby, Kelly N.
    Costa, Luciano J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (03) : 367 - 378
  • [37] Efficacy of Four Drug Regimens in Multiple Myeloma: A Systemic Review
    Ali, Sundas
    Selene, Insija Ilyas
    Tayyeb, Muhammad
    Ahmed, Zahoor
    Khalid, Farhan
    Liaquat, Muhammad Talha
    Jaan, Ali
    Faisal, Muhammad Salman
    Dar, Abdul Jabbar
    Khurshid, Qasim
    Mirza, Muhammad Ali
    Anwer, Faiz
    BLOOD, 2020, 136
  • [38] Activation of coagulation by lenalidomide-based regimens for multiple myeloma
    Arai, R.
    Isozumi, Y.
    Fujimoto, K.
    Koyama, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 592 - 592
  • [39] Efficacy of carfilzomib-based regimens as induction/consolidation therapy in newly diagnosed multiple myeloma: A meta-analysis
    Aiman, Wajeeha
    Ali, Muhammad Ashar
    Usman, Rana Muhammad
    Tehzeeb, Javaria
    Solipuram, Divya
    Bajwa, Umair Farooq
    Parvez, Ateeb
    Tan, Jia Yi
    Ukrani, Janta
    Maroules, Michael
    Anwer, Faiz
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Clinical impact of bortezomib in frontline regimens for patients with multiple myeloma
    Manochakian, Rami
    Miller, Kena C.
    Chanan-Khan, Asher A.
    ONCOLOGIST, 2007, 12 (08): : 978 - 990
12345